Cromos Pharma’s Patient Portal now available in multiple languages
As part of our ongoing commitment to ensuring patients are well informed about their role in the clinical trials process, Cromos Pharma has translated its patient information into multiple languages. At our patients portal, you will now find this information in English, Polish, Georgian, Czech, and Hungarian. You can access our patient portal here. Being a participant in
Cromos Pharma committed to patient centricity in clinical trials
Over the last few years, patient centricity has moved from buzzword to an imperative. Sponsors are now increasingly willing to offer a patient centric approach to studies. However, there remains some confusion over what this means and how to implement it. In this article Cromos Pharma looks at some of the strategies that can be
Cromos Pharma supporting psoriasis clinical research breakthroughs
August is Psoriasis Awareness Month. Cromos Pharma is using this opportunity to underline its commitment to supporting clinical trials to develop new and innovative treatments to improve the lives of millions of psoriasis sufferers around the world. Immune disorder affecting 125 million people worldwide Psoriasis is a complex immune system disorder in which white blood cells,
